Literature DB >> 20965210

Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation).

Nicole M Kane1, Qingzhong Xiao, Andrew H Baker, Zhenling Luo, Qingbo Xu, Costanza Emanueli.   

Abstract

Several types of stem and progenitor cells are currently under investigation for their potential to accomplish vascular regeneration. This review focuses on embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). We will discuss the technologies allowing for their derivation, culture expansion and maintenance in a pluripotent status. Moreover, both ESCs and iPSCs can be differentiated in endothelial cells (ECs) and mural cell, including vascular smooth muscle cells (VSMCs). Here, we will describe the involvements of growth factors (vascular endothelial growth factors-VEGFs-, platet-derived growth factors-PDGFs-), Wnt and Notch signal pathways, reactive oxygen species (ROS), histone deacetylases (HDACs), and microRNAs (miRNAs) in vascular cell differentiation from pluripotent stem cells. We will additionally describe the therapeutic potential of stem cells for vascular medicine.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965210     DOI: 10.1016/j.pharmthera.2010.10.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  35 in total

Review 1.  Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly.

Authors:  Chris A Bashur; Lavanya Venkataraman; Anand Ramamurthi
Journal:  Tissue Eng Part B Rev       Date:  2012-03-02       Impact factor: 6.389

2.  VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.

Authors:  D Zhao; C Pan; J Sun; C Gilbert; K Drews-Elger; D J Azzam; M Picon-Ruiz; M Kim; W Ullmer; D El-Ashry; C J Creighton; J M Slingerland
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

3.  Bioengineering heart muscle: a paradigm for regenerative medicine.

Authors:  Gordana Vunjak-Novakovic; Kathy O Lui; Nina Tandon; Kenneth R Chien
Journal:  Annu Rev Biomed Eng       Date:  2011-08-15       Impact factor: 9.590

Review 4.  Hyperbaric oxygen, vasculogenic stem cells, and wound healing.

Authors:  Katina M Fosen; Stephen R Thom
Journal:  Antioxid Redox Signal       Date:  2014-05-19       Impact factor: 8.401

5.  Murine coagulation factor VIII is synthesized in endothelial cells.

Authors:  Lesley A Everett; Audrey C A Cleuren; Rami N Khoriaty; David Ginsburg
Journal:  Blood       Date:  2014-04-09       Impact factor: 22.113

Review 6.  Stem cells and calcium signaling.

Authors:  Fernanda M P Tonelli; Anderson K Santos; Dawidson A Gomes; Saulo L da Silva; Katia N Gomes; Luiz O Ladeira; Rodrigo R Resende
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells.

Authors:  Mark P White; Abdul J Rufaihah; Lei Liu; Yohannes T Ghebremariam; Kathryn N Ivey; John P Cooke; Deepak Srivastava
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

8.  Adult vascular smooth muscle cells in culture express neural stem cell markers typical of resident multipotent vascular stem cells.

Authors:  Eimear Kennedy; Ciaran J Mooney; Roya Hakimjavadi; Emma Fitzpatrick; Shaunta Guha; Laura E Collins; Christine E Loscher; David Morrow; Eileen M Redmond; Paul A Cahill
Journal:  Cell Tissue Res       Date:  2014-07-04       Impact factor: 5.249

9.  Perspectives on stem cell-based elastic matrix regenerative therapies for abdominal aortic aneurysms.

Authors:  Chris A Bashur; Raj R Rao; Anand Ramamurthi
Journal:  Stem Cells Transl Med       Date:  2013-05-15       Impact factor: 6.940

Review 10.  Small-diameter vascular tissue engineering.

Authors:  Dawit G Seifu; Agung Purnama; Kibret Mequanint; Diego Mantovani
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.